Results 261 to 270 of about 1,754,831 (304)

Chapter 3. Antipsychotic Agents and Dopamine Agonists

1983
Publisher Summary A large number of new compounds are being developed as anti-psychotics, many inspired by the atypical drugs clozapine and sulpiride. The emergence of selective presynaptic dopamine (DA) agonists instead of conventional DA blockers has increased strongly.
openaire   +1 more source

Development of imaging agents for the dopamine transporter

Medicinal Research Reviews, 1995
F I, Carroll, U, Scheffel, R F, Dannals, J W, Boja, M J, Kuhar   +4 more
openaire   +2 more sources

Dopamine Pharmacological Agents in Resistant-OCD

Current Psychopharmacologye, 2012
Stefano Pallanti, Giacomo Grassi, Iuliia Burian   +2 more
openaire   +1 more source

Dopamine D3 receptor agents in schizophrenia

European Neuropsychopharmacology, 1999
P. Sokoloff, J. Diaz, C. Pilon, J.-C. Schwartz   +3 more
openaire   +1 more source

Dopamine receptor ligands and imaging agents.

1990
KUNG HANK F, MURPHY RAYMOND
openaire   +9 more sources

Agent Orange and Cancer: An Overview for Clinicians

Ca-A Cancer Journal for Clinicians, 2003
Howard Frumkin
exaly  

Dopamine-Melanin Colloidal Nanospheres: An Efficient Near-Infrared Photothermal Therapeutic Agent for in Vivo Cancer Therapy

Advanced Materials, 2013
Yanlan Liu, Jianhua Liu, Kelong Ai
exaly  

CLEBOPRIDE: A DOPAMINE RECEPTOR BLOCKING AGENT

InPharma, 1982
openaire   +1 more source

The Effectiveness of Dopamine Stimulating Agents in Depressive Disorder

The American Journal of Geriatric Psychiatry, 2023
openaire   +1 more source

Cancer Chemotherapeutic Agents

Ca-A Cancer Journal for Clinicians, 1981
I H Krakoff
exaly